Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ELACESTRANT vs ELAFIBRANOR: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ELACESTRANT vs ELAFIBRANOR: Safety Overview

Metric ELACESTRANT ELAFIBRANOR
Total FAERS Reports 6,935 356
Deaths Reported 525 4
Death Rate 7.6% 1.1%
Hospitalizations 843 19
Average Patient Age 65.7 yrs 59.8 yrs
% Female Patients 99.1% 96.1%
FDA Approval Date Jan 27, 2023 Jun 10, 2024
Manufacturer Stemline Therapeutics, Inc. Ipsen Biopharmaceuticals, Inc.
Route ORAL ORAL
Marketing Status Prescription Prescription